Search the web
Welcome, Guest
[Sign Out, My Account]
Morningstar_Inc.

Monday, September 1 2014 9:48pm ET - U.S. Markets Closed.
Industry Center - Drug Related Products
Industry Center > Drug Related Products
More On This Industry
Summary
·News
·Leaders & Laggards
· Company Index
·Industry Browser
Related Industries
· Biotechnology
· Diagnostic Substances
· Drug Delivery
· Drug Manufacturers - Major
· Drug Manufacturers - Other
· Drugs - Generic
Top Industries
·Auto Manufacturers - Major
·Biotechnology
·Business Software & Services
·Chemicals - Major Diversified
·Communication Equipment
·Conglomerates
·Diversified Computer Systems
·Diversified Investments
·Diversified Utilities
·Drug Manufacturers - Major
·Electric Utilities
·Food - Major Diversified
·Industrial Metals & Minerals
·Major Airlines
·Major Integrated Oil & Gas
·Money Center Banks
·Property & Casualty Insurance
·Semiconductor - Broad Line
·Telecom Services - Domestic
·Tobacco Products, Other
Complete Industry List...
Morningstar Inc.
In-depth Company Dossier Reports on over 7,500 publicly traded U.S. companies. Click here for your free report.
  
Industry Market Summary
Drug Related Products
Composite Value: 1136.6
Today's Change: -0.72%
S&P 500: +0.33%
chart for
[Drug Related Products (^YHOh787)]
Drug Related Products News
Auxilium Pharmaceuticals, Inc. To Present CCH Data For Concurrent Treatment Of Multiple Dupuytren's Cords At ASSH Annual Meeting
Thu Aug 28 (PR Newswire)
CHESTERBROOK, Pa., Aug. 28, 2014 /PRNewswire/ -- Auxilium Pharmaceuticals, Inc. (AUXL), a specialty biopharmaceutical company, today announced that data from trials evaluating the use of collagenase clostridium histolyticum (CCH) for treating two Dupuytren's contracture (DC) cords concurrently in adult patients with a palpable cord will be presented at the upcoming 69th Annual Meeting of the American Society for Surgery of the Hand (ASSH) being held in Boston on September 18-20, 2014. The AUX-CC-867 MULTICORD (MULtiple Treatment Investigation of Collagenase Optimizing the Resolution of Dupuytrens) study data examining the effect of delayed finger extension on patients who received two concurrent injections of CCH to treat two affected joints in the same hand were selected for the meeting's Best Paper Session. Additionally, a podcast has been selected for presentation that describes an analysis of the MULTICORD study treating two affected joints in the same hand concurrently using local anesthesia prior to finger extension.
Auxilium Pharmaceuticals, Inc. To Present At The Morgan Stanley Healthcare Conference - (PR Newswire)
Despite new highs, Cramer spots a bargain stock - (at CNBC)
More News on Drug Related Products: Latest News,
Industry Top Performers
Intraday Price Performance% ChangeMarket Cap
Lifevantage Corporation [LFVN] +3.25% $131.7 M
Auxilium Pharmaceuticals, Inc. [AUXL] +1.53% $934.8 M
More Top Intraday Price Performers...
Market Capitalization% ChangeMarket Cap
Perrigo Company plc Ordinary Sh [PRGO] -0.86% $19.9 B
USANA Health Sciences, Inc. Com [USNA] -1.23% $948.2 M
Auxilium Pharmaceuticals, Inc. [AUXL] +1.53% $934.8 M
AMEXDRUG CP [AXRX] 0.00% $59.2 M
COCRYSTAL PHARMA [COCP] +5.19% $47.6 M
More Top Companies by Market Cap...
More Top Performers: by Valuation, by Growth, by Financial Strength
Industry Calendar
Recent Events
Date Co Event
08/14/14 PRGO Perrigo Company plc Ordinary Sh upside earnings surprise (+12.26%)
08/07/14 AUXL Auxilium Pharmaceuticals, Inc. downside earnings surprise (-109.52%)
07/29/14 USNA USANA Health Sciences, Inc. Com downside earnings surprise (-9.33%)
More Recent Events...
Sponsor Results
Need a Full Service CRO?
WCCT Global Owns early and late phase CPUs to fit your trial needs.
http://www.wcct.com
Professional Statistician
1-on-1 Collaboration for your Project, Research, or Dissertation
www.OmegaStatistics.com
Accelerated Study Start
Clinical trial site identification, feasibility, and activation.
www.ePharmaSolutions.com
(What's This?)
  
Locate Industry by Company
Enter Symbol:
Industry Statistics
Market Capitalization:22B
Price / Earnings:79.1
Price / Book:-15.1
Net Profit Margin (mrq):7.8%
Price To Free Cash Flow (mrq):-25.5
Return on Equity:4.4%
Total Debt / Equity:46.6
Dividend Yield:0.3%
View Industry Browser
Community Spotlight
Most Active Boards
Board Popularity
NTY
PRGO
DRAX
Unusually Active Boards
Board Variance
AUXL
MTEX
PRGO

RSS Feeds

Add headlines to your
personalized My Yahoo Page
( About My Yahoo and RSS )

Drug Related Products Headlines
More Finance RSS Feeds


Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Industry information © 2014 Morningstar, Inc. All Rights Reserved. Company information © 2014 Capital IQ All Rights Reserved. Quotes and other information supplied by independent providers identified on the Yahoo Finance partner page. S&P 500 index provided by Comstock. All rights reserved. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Capital IQ, Morningstar, CSI and exchanges) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Yahoo site, a user agrees not to redistribute the information found therein.

Questions or Comments?